<SEC-DOCUMENT>0001140361-24-032165.txt : 20240809
<SEC-HEADER>0001140361-24-032165.hdr.sgml : 20240809
<ACCEPTANCE-DATETIME>20240702163207
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001140361-24-032165
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240702

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BeyondSpring Inc.
		CENTRAL INDEX KEY:			0001677940
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR
		STREET 2:		SUITE 410
		CITY:			FLORHAM PARK
		STATE:			NJ
		ZIP:			07932
		BUSINESS PHONE:		646-528-4184

	MAIL ADDRESS:	
		STREET 1:		100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR
		STREET 2:		SUITE 410
		CITY:			FLORHAM PARK
		STATE:			NJ
		ZIP:			07932
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: right; text-indent: 193.5pt;"><img src="ny20030251x4_image01.jpg" height="83" width="261"></div>
    <div><br>
    </div>
    <div style="text-align: center;">July 2, 2024</div>
    <div><br>
    </div>
    <div><u>BY EDGAR</u></div>
    <div><br>
    </div>
    <div>Securities and Exchange Commission</div>
    <div>Division of Corporation Finance</div>
    <div>Office of Life Sciences</div>
    <div>100 F St., N.E.</div>
    <div>Washington, D.C. 20549</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zca78c3a6f5a34ec8a02a4485d93f4d1f" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div>Attn:</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div>Jessica Dickerson</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 96%; vertical-align: top;">
            <div>Chris Edwards</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z14cc918c62ff49e982003401b60c706e" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">
            <div>Re:</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div>BeyondSpring Inc.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 92%; vertical-align: top;">
            <div>Registration Statement on Form F-3</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 92%; vertical-align: top;">
            <div>Filed June 12, 2024</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td style="width: 92%; vertical-align: top;">
            <div>File No. 333-280153</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>Dear Ms. Dickerson and Mr. Edwards:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">BeyondSpring Inc. (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) hereby provides responses to the comments received from the staff (the &#8220;<font style="font-weight: bold;">Staff</font>&#8221;) of
      the United States Securities and Exchange Commission (the &#8220;<font style="font-weight: bold;">Commission</font>&#8221;) set forth in the comment letter dated June 26, 2024 (the &#8220;<font style="font-weight: bold;">Comment Letter</font>&#8221;) with respect to the
      above-referenced Registration Statement on Form F-3 filed with the Commission by the Company on June 12, 2024, File No. 333-280153 (the &#8220;<font style="font-weight: bold;">Registration Statement</font>&#8221;).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">In response to the Staff&#8217;s comments, the Company is filing via Edgar an amendment to the Registration Statement (&#8220;<font style="font-weight: bold;">Amendment No. 1</font>&#8221;) with this response letter.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">The headings and paragraph numbers in this letter correspond to those contained in the Comment Letter and, to facilitate the Staff&#8217;s review, we have reproduced the text of the Staff&#8217;s comments in
      bold below. Capitalized terms used but not defined herein have the meanings given to them in the Registration Statement. All references to page numbers and captions correspond to the page numbers and captions in the Registration Statement.</div>
    <div>
      <div><br>
      </div>
      <div>
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 1px; color: #000000; text-align: center;" align="center" noshade="noshade"></div>
    </div>
    <div style="text-align: center;"> <br>
    </div>
    <div style="text-align: center; font-size: 9pt;">BeyondSpring Inc. | 100 Campus Drive, West Side, 4th Floor, Suite 410 | Florham Park, NJ 07932</div>
    <font style="font-size: 9pt;"> </font>
    <div style="text-align: center; font-size: 9pt;">Main Tel: (646) 305-6387</div>
    <font style="font-size: 9pt;"> </font>
    <div style="text-align: center; font-size: 9pt;">www.beyondspringpharma.com</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div>
      <div style="text-align: right; text-indent: 193.5pt;"><img src="ny20030251x4_image01.jpg" height="83" width="261"></div>
    </div>
    <div><br>
    </div>
    <div><u>Registration Statement on Form F-3</u></div>
    <div><br>
    </div>
    <div><u>General</u></div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3df61dafdd024ba9b031590ec793e449" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-weight: bold;">1.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;">We note your ownership of several PRC subsidiaries, including your majority interest in your Chinese subsidiary that owns 100% of the rights to your lead product candidate in China. We further note that a portion
              of your assets are located in China, that you maintain an office and have employees in China, and that the majority of your patients for certain clinical trials for your lead product candidate are in China. Please clarify for us whether any
              of your officers or directors are also located in China. In addition, to the extent that you do not conduct the majority of your operations in China, please provide us with your analysis supporting this. To the extent that you conduct the
              majority of your operations in China, please revise your filing, as applicable, to provide more specific and prominent disclosures about the legal and operational risks associated with China-based companies. For additional guidance, please
              see the Division of Corporation Finance&#8217;s Sample Letter to China-Based Companies issued by the Staff in December 2021 and the Sample Letter to Companies Regarding China-Specific Disclosures issued by the Staff in July 2023.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><u>Response</u></div>
    <div><br>
    </div>
    <div>The Company respectfully advises the Staff that the Company conducts the majority of its operations in the United States due to the following reasons:</div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7a6f3d7930834baab71a34e0bf019f3e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Company is a Cayman Islands holding company which principally conducts its business operations through its wholly-owned subsidiary, BeyondSpring Pharmaceuticals, Inc. (&#8220;<font style="font-weight: bold;">BeyondSpring US</font>&#8221;), and its
              majority-owned subsidiaries, SEED Therapeutics Inc. (&#8220;<font style="font-weight: bold;">SEED</font>&#8221;) and SEED Therapeutics US, Inc. (&#8220;<font style="font-weight: bold;">SEED US</font>&#8221;).</div>
          </td>
        </tr>

    </table>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc6aefdbfe5d2428caeaacc121ee35de1" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Company&#8217;s business headquarters are located in New Jersey in the United States. BeyondSpring US and SEED US are Delaware corporations and SEED is a British Virgin Islands company headquartered in Pennsylvania in the United States.</div>
          </td>
        </tr>

    </table>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9036eb4b9492454a8e03601a29a58ea9" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Company&#8217;s management team, including its Chief Executive Officer, Dr. Lan Huang, and Chief Scientific Officer, Dr. June Lu, are based in the United States at the Company&#8217;s headquarters. In addition, all members of the Company&#8217;s board
              of directors reside outside of China.</div>
          </td>
        </tr>

    </table>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3b5be46d10a6416e98b96d2729fdadd4" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Even though the majority of the patients for certain clinical trials for the Company&#8217;s lead product candidate are in China, such patients are enrolled (in the U.S., China and other countries) through contractual arrangements with
              third-party contract research organizations. These arrangements, as well as arrangements with other third-party collaborators such as service providers for clinical data management, data analysis and clinical data quality control, are managed
              by the Company&#8217;s employees in the United States.</div>
          </td>
        </tr>

    </table>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9d47090abc0143fe89e8aaedeb3f3bd4" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>A majority of the Company&#8217;s research and development (&#8220;<font style="font-weight: bold;">R&amp;D</font>&#8221;) efforts are for clinical trials and pre-clinical R&amp;D in the United States, through arrangements entered into by either
              BeyondSpring US, SEED or SEED US. During fiscal year 2023, less than 10% of the Company&#8217;s R&amp;D expenses were for clinical trials related operations conducted through the Company&#8217;s Chinese subsidiaries and less than 15% of the Company&#8217;s
              operating expenditures were incurred in China.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div>
      <div>
        <div><br>
        </div>
        <div>
          <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 1px; color: #000000; text-align: center;" align="center" noshade="noshade"></div>
      </div>
      <div style="text-align: center;"> <font style="font-size: 8pt;"><br>
        </font></div>
      <font style="font-size: 8pt;"> </font>
      <div style="text-align: center; font-size: 9pt;">BeyondSpring Inc. | 100 Campus Drive, West Side, 4th Floor, Suite 410 | Florham Park, NJ 07932</div>
      <font style="font-size: 9pt;"> </font>
      <div style="text-align: center; font-size: 9pt;">Main Tel: (646) 305-6387</div>
      <font style="font-size: 9pt;"> </font>
      <div style="text-align: center; font-size: 9pt;">www.beyondspringpharma.com</div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div>
      <div style="text-align: right; text-indent: 193.5pt;"><img src="ny20030251x4_image01.jpg" height="83" width="261"></div>
    </div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd029715ce852470fafe4e0b63f419847" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>Even though the Company&#8217;s Chinese subsidiary owns 100% of the rights in China for its lead asset Plinabulin, the Company owns patent rights to Plinabulin in more than 40 countries outside of China, including some of the largest
              pharmaceutical markets, the U.S., Europe and Japan.</div>
          </td>
        </tr>

    </table>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zecb98ca24d1243a8beea093c89263af6" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Company does not use any variable interest entity (VIE) structure.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>Finally,</div>
    <div><br>
    </div>
    <div><u>Signatures, page II-5</u></div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3205c11136d64cd7aa9b2c1c3f1da25f" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-weight: bold;">2.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;">Please amend your registration statement to include the signatures of your principal financial officer and your controller or principal accounting officer, signing in such capacities. Refer to the instructions
              regarding signatures in Form F-3.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><u>Response</u></div>
    <div><br>
    </div>
    <div>In response to the Staff&#8217;s comments, the Company revised page II-6 of Amendment No.1 to indicate that Dr. Lan Huang is signing as the principal executive officer, principal financial officer and principal accounting officer.</div>
    <div><br>
    </div>
    <div style="text-align: center;">* * * * *</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">We hope that the foregoing has been responsive to the Staff&#8217;s comments and look forward to resolving any outstanding issues as quickly as possible. Please direct any questions or comments regarding
      the foregoing to me at (646) 528-4184.</div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zec8c86d74a43419ca16c846c710a13f0" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 57%; vertical-align: top;">&#160;</td>
          <td style="width: 40%; vertical-align: top;">
            <div>Very truly yours,</div>
          </td>
        </tr>
        <tr>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 57%; vertical-align: top;">&#160;</td>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 57%; vertical-align: top;">&#160;</td>
          <td style="width: 40%; vertical-align: top; border-bottom: 2px solid black;">
            <div>/s/ Lan Huang</div>
          </td>
        </tr>
        <tr>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 57%; vertical-align: top;">&#160;</td>
          <td style="width: 40%; vertical-align: top;">
            <div>Lan Huang</div>
          </td>
        </tr>
        <tr>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 57%; vertical-align: top;">&#160;</td>
          <td style="width: 40%; vertical-align: top;">
            <div>Chief Executive Officer</div>
          </td>
        </tr>
        <tr>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 57%; vertical-align: top;">&#160;</td>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 3%; vertical-align: top;">
            <div>cc:</div>
          </td>
          <td style="width: 57%; vertical-align: top;">
            <div>Michael J. Hong</div>
          </td>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 57%; vertical-align: top;">
            <div>Deni Li</div>
          </td>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 3%; vertical-align: top;">&#160;</td>
          <td style="width: 57%; vertical-align: top;">
            <div style="font-style: italic;">Skadden, Arps, Slate, Meagher &amp; Flom LLP</div>
          </td>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <div>
        <div><br>
        </div>
        <div>
          <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 1px; color: #000000; text-align: center;" align="center" noshade="noshade"></div>
      </div>
      <div style="text-align: center;"> <font style="font-size: 8pt;"><br>
        </font></div>
      <font style="font-size: 8pt;"> </font>
      <div style="text-align: center; font-size: 9pt;">BeyondSpring Inc. | 100 Campus Drive, West Side, 4th Floor, Suite 410 | Florham Park, NJ 07932</div>
      <font style="font-size: 9pt;"> </font>
      <div style="text-align: center; font-size: 8pt;">Main Tel: (646) 305-6387</div>
      <font style="font-size: 8pt;"> </font>
      <div style="text-align: center;"><font style="font-size: 8pt;">www.beyondspringpharma.com</font>
        <hr style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>ny20030251x4_image01.jpg
<TEXT>
begin 644 ny20030251x4_image01.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "# 9@# 2(  A$! Q$!_\0
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M]C4YH3KV493<HJS@XQUZ***_5#[H**** "BBB@ HHHH **** "BBB@ HHHH
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MN+A@X4,;DE>5/%2YL35PCCA'A:L\/3C"G6H4J]\33Y:LVHJI_2]17Y\?'_\
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MQN+ITL34>"Q*FJ;P^-P\*$L5A*T9RC&5/$4*<HN<$TN>'-^I=?GW_P % _\
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M+Y:LV ?Y]_@]\$?&/B7XVZSX>^'/[1'@GXQ_"7Q;-J>C^,-+UGQWJ+:UXE\
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M@_&&MZAX;\+Z]K^E>'M1\6ZEI&F75_9>&=(D@BU/7+BWC+Q:;8R73);I<W+
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M_@X" ;]MKP(K ,K?"KPNK*W*LK>)E5E93P592593PRD@@@FOU+_X+00PP?\
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M*TH3BI1DNTHR337DT*48SBXSBI1>CC)*46NS3NG\Q%55 55"J  %48
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MV1_V@_A.(3X$_;-^(7B&U@;<N@?%7P[I'B_1YA@ QM<&6/4X P&TR0S;UX<
ML!7VCX)G\??8/LOQ L]!&K0"-!J?AJXN6TS4<##S"TO0+JRE)!9HB7C&<(^,
M =Q17KT,+2PVE%U8P_Y]RK5:L-K:*K.?+_VZXKO<X*E:=76HH.7\RIPA+YN$
M8W_[>NPHHHKI,0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@"GYLG][]!_A1YLG][]!_A110 >;)_>_0?X4>;)_>_0?X444
M 'FR?WOT'^%'FR?WOT'^%%% !YLG][]!_A1YLG][]!_A110 >;)_>_0?X4>;
M)_>_0?X444 'FR?WOT'^%'FR?WOT'^%%% !YLG][]!_A1YLG][]!_A110 >;
M)_>_0?X4>;)_>_0?X444 'FR?WOT'^%'FR?WOT'^%%% !YLG][]!_A1YLG][
M]!_A110 >;)_>_0?X4>;)_>_0?X444 'FR?WOT'^%'FR?WOT'^%%% !YLG][
M]!_A1YLG][]!_A110 >;)_>_0?X4>;)_>_0?X444 'FR?WOT'^%'FR?WOT'^
M%%% !YLG][]!_A1YLG][]!_A110 >;)_>_0?X4>;)_>_0?X444 'FR?WOT'^
M%'FR?WOT'^%%% !YLG][]!_A1YLG][]!_A110 >;)_>_0?X4>;)_>_0?X444
M 'FR?WOT'^%'FR?WOT'^%%% !YLG][]!_A1YLG][]!_A110 >;)_>_0?X4>;
M)_>_0?X444 'FR?WOT'^%'FR?WOT'^%%% !YLG][]!_A1YLG][]!_A110 >;
,)_>_0?X4444 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
